Madrigal Pharmaceuticals, Inc. Stock Company Profile
Information
Four Tower Bridge, Suite 200 200 Barr Harbor Drive
West Conshohocken PA 19428
267 824 2827
www.madrigalpharma.com
Industry: Biotechnology
Sector: Healthcare
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.